Inventor

ZHANG XIQUAN

CN50 patents

⚠️ This page may combine multiple inventors who share the name “ZHANG XIQUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHANG XIQUAN

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same

Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same

Synthesis process of ruxolitinib

1,3,5-triazine derivative and method of using same

Quinoline derivative for treatment of triple-negative breast cancer

Diarylthiohydantoin compound as androgen receptor antagonist

Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor

Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor

Preparation method for chiral pyrrolopyrimidine compound

Quinoline derivative for treatment of nasopharyngeal carcinoma

Diarylthiohydantoin compound as androgen receptor antagonist

Crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereof

Salts of quinazoline derivative and method for preparing the same

Therapeutic combination of quinoline derivative and antibody

TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof

TLR7 agonist and pharmaceutical combination thereof for treating lung cancer

Quinoline derivative for treating rheumatoid arthritis

Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome

Azetidine derivative

Method for preparing trifluridine

Combined pharmaceutical composition for treating tumor

Crystalline sulfamide compound

Preparation method for CDK4/6 inhibitor

Resorcinol derivative as HSP90 inhibitor

Borate of azetidine derivative

Drug combination containing TLR7 agonist

Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof

Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal

Pyridine-substituted 2-aminopyridine protein kinase inhibitors

Pyrrolopyrimidine crystal for preparing JAK inhibitor

6-aryl amino pyridone formamide compound crystal and preparation method therefor

Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor

Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases

Bicylic compound acting as an inhibitor

Method for preparing cholic acid compound

Crystals of quinolone derivatives

Crystal of DPP-IV long-acting inhibitor and salt

Crystal form and salt form of bromine domain protein inhibitor and preparation method therefor

M-dihydroxybenzene derivative crystal and salt, and manufacturing method thereof

Antitumor compound targeting IDH2 mutation and method of use thereof

HUAWEI TECH CO LTD

Method and apparatus for generating physical network topology

Data transmission time obtaining method, apparatus, and system

Latency-based transmission path control method, network controller, and system

Delay measurement method of network node device, apparatus, and network node device

Delay measurement method and device

NANJING SHUNXIN PHARMACEUTICAL CO LTD

Pharmaceutical composition of humanized monoclonal anti-PD-L1 antibody

LIU YANLONG

Lamivudine oxalate and preparation method thereof

SHANGHAI DUDE MEDICAL SCIENCE AND TECH CO LTD

Process for preparing ibrutinib

ZHANG AIMING

Crystalline forms of tenofovir dipivoxil fumarate